Electroresponsive Nanoparticles Improve Antiseizure Effect of Phenytoin in Generalized Tonic-Clonic Seizures. - Wikidata - awgldk - TriplyDB

Electroresponsive Nanoparticles Improve Antiseizure Effect of Phenytoin in Generalized Tonic-Clonic Seizures.

Electroresponsive Nanoparticles Improve Antiseizure Effect of Phenytoin in Generalized Tonic-Clonic Seizures.

http://www.wikidata.org/entity/Q37136454

about

Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.Phenytoin: 80 years young, from epilepsy to breast cancer, a remarkable molecule with multiple modes of action.Design strategies for physical-stimuli-responsive programmable nanotherapeutics

P2860

Q38937398-023C2796-B623-4114-B4FB-52A9032A007F Q39084955-2F1D8671-3A54-4B24-B909-56CC6FA87A78 Q57357734-65A44DCA-21FA-4C60-9378-04ACDF16A4B5

P2860

Electroresponsive Nanoparticles Improve Antiseizure Effect of Phenytoin in Generalized Tonic-Clonic Seizures.

http://www.wikidata.org/entity/Q37136454

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Electroresponsive Nanoparticle ...... ralized Tonic-Clonic Seizures.

@en

Electroresponsive Nanoparticle ...... ralized Tonic-Clonic Seizures.

@nl

type

label

Electroresponsive Nanoparticle ...... ralized Tonic-Clonic Seizures.

@en

Electroresponsive Nanoparticle ...... ralized Tonic-Clonic Seizures.

@nl

prefLabel

Electroresponsive Nanoparticle ...... ralized Tonic-Clonic Seizures.

@en

Electroresponsive Nanoparticle ...... ralized Tonic-Clonic Seizures.

@nl

P1433

Q37136454-F5BAA4BA-6478-4214-9A99-203CE76C2B66

P1476

Q37136454-39C144ED-D7B1-42BA-B0DC-94EB54883BF0

P2093

Q37136454-083FADF4-4CB1-4F20-AF98-58575A1DD993

Q37136454-4A329183-63CB-4721-82F9-67A1F3FD034C

Q37136454-5C8188B8-B2BF-4FDD-84E0-AC56BEE5902A

Q37136454-5FB8BEFB-F7A1-4CFE-ACBE-96AD26073789

Q37136454-6EC298DA-F9D6-4DA5-AED8-52DA125358B3

Q37136454-7970A287-9645-44C8-AD82-A1E86D7CF536

Q37136454-7DE6FF47-23D0-4DBA-AFE6-828CFA07AABD

Q37136454-804380D2-1C46-46BE-89E8-D7E6657B10CD

Q37136454-8EBAFC21-4864-45A1-918A-369B995C0F69

Q37136454-D19C11EA-093F-470E-A8AA-F8A886403DCE

P2860

Q37136454-07F5371A-D911-429E-84CC-EAD9B0D35F43

Q37136454-0AACBC50-C860-42CF-902A-0E3310B1DD19

Q37136454-0CC00CB2-B0FF-4826-80B1-016F4FD896D7

Q37136454-0FA4F7BC-4664-4DA1-B619-B0E827FF3A7C

Q37136454-135DF5E1-2822-41B5-AD1B-678C079A4459

Q37136454-16DD3961-9AFF-44DD-AE60-E39A4AE94494

Q37136454-1FCAD230-1FB5-4A23-970D-23CE72655D00

Q37136454-24F09B9F-542F-44F5-809B-7D3C890B08C2

Q37136454-2885EFDC-1A05-4832-9893-FD8ECF5D7715

Q37136454-2B0C3B35-136B-4DEB-A883-4BA1CA8F75A4

P2888

Q37136454-DA69A0B1-4B2B-48DA-A101-950F44C73EEC

P304

Q37136454-6D2D8EDE-BAEA-4D56-B7E5-3543ED6C5431

P31

Q37136454-1D91DDC2-0304-4FD6-AA3F-8F7B272373F6

P356

Q37136454-A7D61980-4A5D-4971-B4B7-B40EC31DE433

P433

Q37136454-4FC87A65-9880-44DF-B58B-9EF91D2729BF

P478

Q37136454-5A6FE33B-E34B-4222-B421-A1DA9D2A9F71

P577

Q37136454-417C792A-EDB8-4AAB-B960-4AE6884AAACA

P698

Q37136454-19014399-147D-4B57-AA96-F02A2A50CFF3

P921

Q37136454-F6A6DE57-7AB4-4A1C-83A8-3F5D70B7E3A4

P932

Q37136454-50559076-84AA-421A-8202-596E60A26C11

P356

S13311-016-0431-9

P1433

Neurotherapeutics

P1476

Electroresponsive Nanoparticle ...... ralized Tonic-Clonic Seizures.

@en

P2093

Cenglin Xu

http://www.w3.org/2001/XMLSchema#string

Jiao Liang

http://www.w3.org/2001/XMLSchema#string

Liying Chen

http://www.w3.org/2001/XMLSchema#string

Shuang Wang

http://www.w3.org/2001/XMLSchema#string

Weiwei Hu

http://www.w3.org/2001/XMLSchema#string

Xiaoying Ying

http://www.w3.org/2001/XMLSchema#string

Yao Liu

http://www.w3.org/2001/XMLSchema#string

Yi Guo

http://www.w3.org/2001/XMLSchema#string

Yi Wang

http://www.w3.org/2001/XMLSchema#string

Ying Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Dendrimer advances for the central nervous system delivery of therapeutics

Modification of seizure activity by electrical stimulation. II. Motor seizure

The neurobiology of antiepileptic drugs

Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs.

Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959-2009.

Brain stimulation for epilepsy.

Molecular and cellular mechanisms of pharmacoresistance in epilepsy.

Update on pharmacogenetics in epilepsy: a brief review.

Drug release from electric-field-responsive nanoparticles.

Drug treatment of epilepsy in the century of the ILAE: the first 50 years, 1909-1958.

P2888

s13311-016-0431-9

P304

603-613

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13311-016-0431-9

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27137202

http://www.w3.org/2001/XMLSchema#string

P921

P932

4965401

http://www.w3.org/2001/XMLSchema#string